glp 1 heavy period Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Primary Care in Rochester and

in silymarin

Lipid dysregulation further induces mitochondrial dysfunction and ER stress, triggering oxidative damage and inflammatory cascades that form self-amplifying pathological cycles

Neuroprotection by glial cells through adult T cell leukemia-derived factor/human thioredoxin (ADF/TRX)

Read the full story here To view or add a comment, sign in One of the most interesting recent developments in the pharmaceutical industry is the patent expiry of Semaglutide in India (March 2026) , which may significantly improve access to advanced diabetes and obesity treatments

The type I insulin-like growth factor receptor regulates cancer metastasis independently of primary tumor growth by promoting invasion and survival

While treatment strategies for AD have principally targeted individual pathological hallmarks such as amyloid and tau with limited success in modifying the disease course, to have an effective disease-modifying treatment it may be necessary to target multiple pathologies [8, 9]